Amino Acid Solutions for (177)Lu-Oxodotreotide Premedication: A Tolerance Study

SIMPLE SUMMARY: [(177)Lu]oxodotreotide (Lutathera(®)) was approved by the European Medical Agency in 2017 and the Food and Drug Administration in 2018 for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors as the first radiopharmaceutical for peptide recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Courault, Pierre, Deville, Agathe, Habouzit, Vincent, Gervais, Frédéric, Bolot, Claire, Bournaud, Claire, Levigoureux, Elise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657593/
https://www.ncbi.nlm.nih.gov/pubmed/36358631
http://dx.doi.org/10.3390/cancers14215212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657593/
https://www.ncbi.nlm.nih.gov/pubmed/36358631
http://dx.doi.org/10.3390/cancers14215212

Ejemplares similares